Video

leva Pelvic Health System shows efficacy for improving symptoms of urinary incontinence

Author(s):

Urology Times staff

“We had fantastic completion of the study, and we were very pleased with the results,” says Samantha Pulliam, MD.

Current Time 0:00
Duration 5:58
Loaded: 2.74%
Stream Type LIVE
Remaining Time 5:58
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected

    In this video, Samantha Pulliam, MD, discusses the background and key findings for the Obstetrics & Gynecology study, “Digital therapeutic device for urinary incontinence: a randomized controlled trial.” Pulliam is chief medical officer for Renovia Inc.

    Related Videos
    Human kidney stones | Image Credit: © freshidea - stock.adobe.com
    Study results show CVAC 2.0 is safe, efficacious for wide range of kidney stones
    De novo metastatic prostate cancer: Understanding Biden’s prognosis and treatment
    De novo metastatic prostate cancer: Understanding Biden’s prognosis and treatment
    Geoffrey Sonn, MD, on an AI risk mapping tool to predict seminal vesicle invasion
    Geoffrey Sonn, MD, on an AI risk mapping tool to predict seminal vesicle invasion
    Woman talking with doctor | Image Credit: © Liudmila Dutko - stock.adobe.com
    Alternative treatments and patient communication for genitourinary syndrome of menopause
    Amir Patel, MD, on ureteral strictures following holmium vs TFL laser lithotripsy
    Amir Patel, MD, on ureteral strictures following holmium vs TFL laser lithotripsy
    Prostate cancer screening: Expert weighs in after Biden's diagnosis
    Prostate cancer screening: Expert weighs in after Biden's diagnosis
    Sarah Razavi, MD, answers a question during a Zoom video interview
    Sarah Razavi, MD, discusses the physical toll of ureteroscopy on urologists
    Man talking with a doctor | Image Credit: © Chinnapong - stock.adobe.com
    Study results affirm effectiveness of evolving prostate cancer therapies
    Laura Davis, MD, on link between microplastics and bladder cancer
    Laura Davis, MD, on link between microplastics and bladder cancer
    Roger Dmochowski, MD, on real-world persistence with vibegron for OAB
    Roger Dmochowski, MD, on real-world persistence with vibegron for OAB
    Related Content
    Addressing an unmet need: CELLEBRATE trial explores cell-based therapy for recurrent SUI
    May 16th 2025

    Addressing an unmet need: CELLEBRATE trial explores cell-based therapy for recurrent SUI

    Melissa Kaufman, MD, PhD, FACS Hannah Clarke
    The CELLEBRATE trial is aiming to provide additional evidence to support the safety and efficacy of iltamiocel.
    Dr. Dobberfuhl discusses novel onabotulinumtoxinA treatment for refractory OAB
    March 21st 2022

    Dr. Dobberfuhl discusses novel onabotulinumtoxinA treatment for refractory OAB

    Urology Times staff
    “This technique is feasible, it is very well tolerated, and there’s not much of a complication rate, so it appears to be very safe,” says Amy D. Dobberfuhl, MD, MS.
    Artificial urinary sphincter for SUI shows safety, efficacy in prospective study
    May 9th 2025

    Artificial urinary sphincter for SUI shows safety, efficacy in prospective study

    Melissa Kaufman, MD, PhD, FACS Hannah Clarke
    "This trial will be the benchmark for research reporting in the future," says Melissa R. Kaufman, MD, PhD, FACS.
    Destigmatizing Urology: Dr. Alexandra Rogers discusses OAB
    March 18th 2022

    Destigmatizing Urology: Dr. Alexandra Rogers discusses OAB

    Urology Times staff
    “We need to improve the fact that 75% of these patients are untreated [or] unmanaged and frustrated,” says Alexandra Rogers, MD.
    First patient enrolled in trial of Voro Urologic Scaffold for post-prostatectomy SUI
    April 24th 2025

    First patient enrolled in trial of Voro Urologic Scaffold for post-prostatectomy SUI

    Hannah Clarke
    "What is truly exciting is the potential for this device to meaningfully improve early and long-term continence rates, which can profoundly impact a patient's recovery and overall quality of life,” says Patrick Daily, MD.
    Neuromodulation device shows promising efficacy for neurogenic bladder
    April 16th 2025

    Neuromodulation device shows promising efficacy for neurogenic bladder

    Hannah Clarke
    Data from the pivotal CONTINENCE trial showed encouraging efficacy of SCONE neuromodulation therapy.
    © 2025 MJH Life Sciences

    All rights reserved.